Correlations between Carcinoembryonic Antigen, Epidermal Growth Factor and Leptin in Patients with Non-Small-Cell Lung Cancer
DOI:
https://doi.org/10.6000/1927-7229.2014.03.01.2Keywords:
Non-small-cell lung cancer, Carcinoembryonic antigen (CEA), Epidermal growth factor (EGF), Leptin, Immunofluorescence, Correlation.Abstract
Objectives:Carcinoembryonic antigen (CEA), epidermal growth factor (EGF) and leptin have been reported to be intimately intertwined in lung carcinogenesis.However, few studies have simultaneously examined these proteins in lung cancer and whether a correlation exist among them remains unclear. Here, we compared the levels of CEA, EGF and leptin in non-small-cell lung cancer (NSCLC) patients and controls and evaluated the possible associations among them.
Methods:97 patients ranged from 30 to 83 years of age were studied. Serum CEA, EGF and leptin levels were determined following a standard protocol. The relationships between these proteins and clinicopathological factors were evaluated by Wilcoxon rank sum or Kruskal-Wallis H test. Spearman rank-correlation were used to determine the correlations among CEA, EGF and leptin. Co-expression of these proteins in NSCLC tissues was examined by immunofluorescence.
Results: Serum CEA and leptin levels in NSCLC patients were significantly higher compared to controls (both P = 0.000), but no statistically significant difference was found for EGF. CEA and EGF were not associated with the tumor-related factors, but leptin was strongly correlated with sex (P = 0.005). Significant correlations among these proteins were found when the patients were categorized into subgroups. Co-expresstion of these proteins was significantly enhanced with lung carcinogenesis.
Conclusions:CEA, EGF and leptin may interplay and play vital roles in the pathogenesis of NSCLC. Besides CEA, the leptin levels were also significantly higher in NSCLC patients than in controls. Determination of preoperative leptin levels may prove useful for screening and predicting NSCLC.
References
Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. Cancer J Clin 2010; 60: 277-300. http://dx.doi.org/10.3322/caac.20073
Schwartz AG, Wenzlaff AS, Prysak GM, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol 2007; 25: 5785-92. http://dx.doi.org/10.1200/JCO.2007.13.3975
Terzidis A, Sergentanis TN, Antonopoulos J, et al. Elevated Serum Leptin Levels: A Risk Factor for Non-Small-Cell Lung Cancer? Oncology 2009; 76: 19-25. http://dx.doi.org/10.1159/000177952
Ford CHJ, Stokes HJ, Newman CE. Carcinoembryonic antigen and prognosis after radical surgery for lung cancer: immunhistochemical localization and serum levels. Br J Cancer 1981; 44: 145-53. http://dx.doi.org/10.1038/bjc.1981.164
Grunnet M, Sorensen JB. Carcinoembryonic antigen (CEA) as tumor marker in lung cancer. Lung Cancer 2012; 76: 138-43. http://dx.doi.org/10.1016/j.lungcan.2011.11.012
Cohen S. Isolation of a mouse submaxillary gland protein accelerating incisor eruption and eyelid opening in the new-born animal. J Biol Chem 1962; 237: 1555-62.
Carpenter G, Cohen S. Epidermal growth factor. Annu Rev Biochem 1979; 48: 193-216. http://dx.doi.org/10.1146/annurev.bi.48.070179.001205
Mello RA, Ferreira M, Costa S, et al. Association between EGF +61 genetic polymorphisms and non-small cell lung cancer increased risk in a Portuguese population: a case-control study. Tumor Biol 2012; 33: 1341-48. http://dx.doi.org/10.1007/s13277-012-0382-7
Tseng CL, Wu SY, Wang WH, et al. Targeting efficiency and biodistribution of biotinylated-EGF-conjugated gelatin nanoparticles administered via aerosol delivery in nude mice with lung cancer. Biomaterials 2008; 29: 3014-22. http://dx.doi.org/10.1016/j.biomaterials.2008.03.033
Agarwal V, Lind MJ, Cawkwell L. Targeted epidermal growth factor receptor therapy in malignant pleural mesothelioma: Where do we stand? Cancer Treat Rev 2011; 37: 533-42. http://dx.doi.org/10.1016/j.ctrv.2010.11.004
Garofalo C and Surmacz E. Leptin and Cancer. J Cell Physiol 2006; 207: 12-22. http://dx.doi.org/10.1002/jcp.20472
Artac M, Altundag K. Leptin and breast cancer: an overview. Med Oncol 2012; 29: 1510-14. http://dx.doi.org/10.1007/s12032-011-0056-0
Goodwin PJ, Ennis M, Fantus IG, et al. Is Leptin a Mediator of Adverse Prognostic Effects of Obesity in Breast Cancer? J Clin Oncol 2005; 23: 6037-42. http://dx.doi.org/10.1200/JCO.2005.02.048
Xu YJ, Shao YF, Zhao X, Geng YT, Wang K, Yin M. Expression and clinical significance of leptin, the functional receptor of leptin (OB-Rb) and HER-2 in non-small-cell lung cancer: a retrospective analysis. J Cancer Res Clin Oncol 2011; 137: 1841-8. http://dx.doi.org/10.1007/s00432-011-1054-5
Alema´n MR, Santolaria F, Batista N, et al. Leptin role in advanced lung cancer. A mediator of the acute phase response or a marker of the status of nutrition? Cytokine 2002; 19: 21-6. http://dx.doi.org/10.1006/cyto.2002.1051
Kerenidi T, Lada M, Tsaroucha A, Georgoulias P, Mystridou P, Gourgoulianis KI. Clinical significance of serum adipokines levels in lung cancer. Med Oncol 2013; 30: 507-14. http://dx.doi.org/10.1007/s12032-013-0507-x
Ribeiro R, Araujo AP, Coelho A, et al. Medeiros: A functional polymorphism in the promoter region of leptin gene increases susceptibility for non-small cell lung cancer, Eur J Cancer 2006; 42: 1188-93. http://dx.doi.org/10.1016/j.ejca.2006.02.004
Zhang JY, Deng ZH, Liao J. et al. Leptin attenuates cerebral ischemia injury through the promotion of energy metabolism via the PI3K/Akt pathway. J Cerebr Blood F Met 2013; 33: 567-74. http://dx.doi.org/10.1038/jcbfm.2012.202
Ishikawa M, Kitayama J, Nagawa H. Enhanced expression of leptin and leptin receptor (OB-R) in human breast cancer. Clin Cancer Res 2004; 10: 4325-31. http://dx.doi.org/10.1158/1078-0432.CCR-03-0749
Fiorio E, Mercanti A, Terrasi M, et al. Leptin/HER2 crosstalk in breast cancer: in vitro study and preliminary in vivo analysis. BMC Cancer 2008; 8: 305-15. http://dx.doi.org/10.1186/1471-2407-8-305
Soma D, Kitayama J, Yamashita H, Miyato H, Ishikawa M, Nagawa H. Leptin augments proliferation of breast cancer cells via transactivation of HER2. J Surg Res 2007; 149: 9-14. http://dx.doi.org/10.1016/j.jss.2007.10.012
Downloads
Published
Issue
Section
How to Cite
Similar Articles
- Badr AbdullGaffar, Neoplasms and Tumor-Like Lesions of the Hand , Journal of Analytical Oncology: Vol. 1 No. 2 (2012)
- Martin Czejka, Andreas Kiss, Eva Ostermann, Johannes Schueller, Mansoor Ahmed, Najia Mansoor, Tasneem Ahmad, Metabolic Activation and Inactivation of Irinotecan when Combined with the Human Monoclonal Antibody Bevacizumab , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Pedro Salinas Hernández, Rafael Trujillo Vilchez, Antonio Arriví García-Ramos, Rosana Grande Ladron de Guevara, Angeles Rodríguez Jaraiz, Pedro Gallurt Moreira, Jose Maria Vieitez de Prado, Miguel Ruiz López de Tejada, Antonio Irigoyen Medina, Juan Manuel Campos Cervera, Juan Carlos Cámara Vicario, Uriel Bohn Sarmiento, Pedro López Tendero, Juan Domingo Alonso Lajara, Ana León Carbonero, Marisa García de Paredes, Juan de Alvaro Liaño, Asunción Juarez Marroquí, Luis López Gómez , Diego Soto de Prado Otero, Bevacizumab Plus Chemotherapy as First-Line Treatment for Patients with Metastatic Colorectal Cancer: Results from a Spanish Observational Study , Journal of Analytical Oncology: Vol. 2 No. 3 (2013)
- A.S. Kirthi Koushik, R.C. Alva, Brachytherapy in Head and Neck Cancer: A Forgotten Art or a Skill to be Remembered!! , Journal of Analytical Oncology: Vol. 6 No. 1 (2017)
- Yaqin Yuan, Hao Qiu, Jingdong Gao, Zerong Wang, Chunliang Liu, Zhenhua Liu, Zhi Jiang, Yongjian Li, Shiliang Wu, Triptolide Inhibits MCF-7 and HepG2 Cells Invasion and Migration by Inhibiting the Synthesis of Polylactosamine Chains , Journal of Analytical Oncology: Vol. 5 No. 3 (2016)
- L. Thorslund, M. Falk, Patient Performed Reading of a Phototest - A Reliable Method? , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- David Wetherell, Kiran Manya, Nathan Papa, Danny Chui, Nathan Lawrentschuk, Saving Nephrons: Current Surgical Options in Partial Nephrectomy , Journal of Analytical Oncology: Vol. 1 No. 1 (2012)
- Mathilde E. Boon , Pio Zeppa, The Efficacy of Using the Tissue Fragments Present in Cervical Scrapes for the Histologic Diagnosis of Cervical Neoplasia , Journal of Analytical Oncology: Vol. 2 No. 1 (2013)
- Bülent Özgönenel, Öner Özdemir, Melike Özgönenel,, Ronald Thomas, Steven Buck , Süreyya Savasan , The Effect of Pretreatment with Chemotherapeutic Drugs on the Susceptibility to Lymphokine Activated CD8+ T Lymphocyte-Mediated Cytotoxicity in CMK Leukemia Cells , Journal of Analytical Oncology: Vol. 2 No. 4 (2013)
- Maria Caffo, Maria Angela Pino, Gerardo Caruso, Francesco Tomasello, Antisense Molecular Therapy in Cerebral Gliomas , Journal of Analytical Oncology: Vol. 1 No. 2 (2012)
You may also start an advanced similarity search for this article.